CYP3A5 phenotype-genotype correlations in a British population.
about
Genetic variability in CYP3A5 and its possible consequences.Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patientsImpact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patientsTacrolimus and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: An interaction study in CYP3A5 non-expressors, renal transplant recipients.Antimycotic drug discovery in the age of genomics.Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the "Missing Heritability" ProblemHas the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics.Pharmacogenetics of drug metabolizing enzymes in the United Kingdom population: review of current knowledge and comparison with selected European populations.Genotyping of the A6986G polymorphism of CYP3A5CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man?Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements.Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients.Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients.Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation.
P2860
Q30341330-849169E5-6600-44DC-BD53-A1515119C767Q34906432-F2982FB0-8AEF-40DE-9470-0C2DCF86D062Q34976487-59DF1CAA-6CF6-4F1C-88E2-AA3DC351C429Q35157102-160F1D39-A01C-420B-A388-1FB1D45204C0Q36334753-8DD2E427-2803-4FDE-B99D-EEF85F8A6A48Q36634077-76A1B46E-42D2-440F-97BB-2B6C2983C997Q37904672-C862EDFB-8BE9-4E15-9242-C36D971B5F18Q38388873-078A1C13-A7D5-4988-A8F5-5A10F007509CQ42759806-FF6EF9A2-C3BF-4885-86CC-741926F550FFQ44273424-1347BC26-E18A-4081-B045-221EC99D98ECQ44386060-0CC1365C-4BBD-4976-BCE3-2FED1D63B6FDQ46894635-F9CA4720-E844-4CF6-84EE-70B02555E8F7Q48113822-393C0BA4-BE47-4D80-B1FB-49F9A9907D18Q51297212-CF689C8A-A968-4532-BE93-8CFEB5135B82Q54576089-607F9782-13FF-4FC1-8A9A-A5A789468637
P2860
CYP3A5 phenotype-genotype correlations in a British population.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
CYP3A5 phenotype-genotype correlations in a British population.
@ast
CYP3A5 phenotype-genotype correlations in a British population.
@en
type
label
CYP3A5 phenotype-genotype correlations in a British population.
@ast
CYP3A5 phenotype-genotype correlations in a British population.
@en
prefLabel
CYP3A5 phenotype-genotype correlations in a British population.
@ast
CYP3A5 phenotype-genotype correlations in a British population.
@en
P2093
P2860
P1476
CYP3A5 phenotype-genotype correlations in a British population.
@en
P2093
Ann K Daly
Barry P King
Elaine Mutch
Faith M Williams
Julian B S Leathart
P2860
P304
P356
10.1046/J.1365-2125.2003.01798.X
P407
P577
2003-06-01T00:00:00Z